Evidence map›Paper›PMID 36138277›Full record

Observational studyJournal of general internal medicine2023

Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020.

Daniel M Walker, Christine M Swoboda, Karen Shiu-Yee, Willi L Tarver, Timiya S Nolan, Joshua J Joseph

Abstract readObservational Study
In one paragraph

Observational study in Journal of general internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Knowledgeable Language Models as Black-Box Optimizers for Personalized Medicine.... International Conference on Learning Representations · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Walker et al.: Diversity in Clinical Trials.Journal of general internal medicine · 2023
    Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Daniel M WalkerDepartment of Family and Community Medicine, College of Medicine, The Ohio State University, 700 Ackerman Ave, Suite 4000, Columbus, OH, 43202, USA. Daniel.Walker@osumc.edu.ORCID 0000-0001-5434-3162
Christine M SwobodaThe Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), College of Medicine, The Ohio State University, Columbus, OH, USA.
Karen Shiu-YeeThe Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), College of Medicine, The Ohio State University, Columbus, OH, USA.
Willi L TarverThe Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), College of Medicine, The Ohio State University, Columbus, OH, USA.
Timiya S NolanCollege of Nursing, The Ohio State University, Columbus, OH, USA.
Joshua J JosephDivision of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.

Funding

The Role of The Renin-Angiotensin-Aldosterone System, ARMC5, and Neprilysin in Glucose Metabolism among African AmericansK23DK117041 · NIDDK · OHIO STATE UNIVERSITY · PI JOSEPH, JOSHUA J · 2018 to 2022
$1.0M
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors in TreatmentK08CA245208 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NOLAN, TIMIYA S · 2020 to 2024
$895k
NCI NIH HHS K08 CA245208NCI NIH HHS K08CA245208NIDDK NIH HHS K23 DK117041NIDDK NIH HHS K23DK117041
6 · The paper itself

Abstract

backgroundClinical trial diversity is critical to advance health and health equity. Research addressing the discrepancy between goals of achieving clinical trial diversity and realities of study enrollment remains underdeveloped.

objectiveThis study aims to examine the association between race/ethnicity and clinical trial invitation, participation, knowledge, and sources of influence on clinical trial participation. DESIGN AND

participantsA cross-sectional, observational study using nationally representative data from 3689 US adults (≥ 18 years of age) who responded to the Health Information National Trends Survey fielded from February 24 to June 15, 2020. MAIN MEASURES: Primary outcomes included clinical trial invitation, participation, knowledge, and sources of influence on participation. The independent variable of interest is self-reported race/ethnicity. KEY

resultsRespondents identifying as non-Hispanic Black (relative to non-Hispanic White) had higher odds of being invited into a clinical trial (adjusted odds ratio: 2.0, 95% confidence interval (CI): 1.1, 3.7), but no differences in odds of participation were observed by race/ethnicity. Respondents from all races/ethnicities reported that personal healthcare providers were the most trusted source of clinical trial information. Hispanic (marginal effect (ME): - 0.09; 95% CI: - 0.16, - 0.03), non-Hispanic Black (ME: - 0.11; 95% CI: - 0.18, - 0.04), and non-Hispanic other (ME: - 0.11; 95% CI: - 0.19, - 0.02) respondents had lower odds than non-Hispanic White respondents of saying they would be influenced "a lot" by their doctor encouraging participation. Non-Hispanic Black respondents had significantly lower odds (relative to non-Hispanic White) of indicating family encouragement would influence their clinical trial participation decision "a lot" (ME: - 0.09; 95%: CI: - 0.14, - 0.03).

conclusionWhile personal healthcare providers were trusted sources of information, racial/ethnic minority populations noted lower odds of clinical trial participation influence from providers and family. Thus, it is imperative for the healthcare, government, and industry organizations to build trust in medicine and science.

Indexed as

Clinical Trials as TopicEthnicityMinority GroupsPatient ParticipationAdultCross-Sectional StudiesHumansSurveys and QuestionnairesUnited Statesclinical trialsdiversityhealth equityHINTSNCI

Identifiers

PMID36138277
PMCPMC10039144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.